BRIEF-Phathom Pharmaceuticals Submits Citizen Petition To FDA

Reuters12-11
BRIEF-<a href="https://laohu8.com/S/PHAT">Phathom Pharmaceuticals</a> Submits Citizen Petition To FDA

Dec 11 (Reuters) - Phathom Pharmaceuticals PHAT.O:

  • PHATHOM PHARMACEUTICALS SUBMITS CITIZEN PETITION TO FDA SEEKING CORRECTION OF ORANGE BOOK LISTINGS FOR VOQUEZNA® (VONOPRAZAN) TABLETS

  • PHATHOM: PETITION REQUESTS CORRECTION OF ORANGE BOOK LISTINGS FOR VOQUEZNA 10 MG,20 MG TABLETS TO ACCURATELY REFLECT 10-YEAR NCE EXCLUSIVITY PERIOD

  • PHATHOM PHARMACEUTICALS INC: EXCLUSIVITY PERIOD IS UNTIL MAY 3, 2032

Source text: ID:nGNXMt0NF

Further company coverage: PHAT.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment